Repeat PA screening after correcting hypokalemia if initial screen negative
STEP 1 — Gather Information
Collect serum potassium, plasma aldosterone, plasma renin activity (or direct renin concentration), calculate aldosterone-to-renin ratio (ARR), and review medication list for interfering agents (e.g., MRAs, ACEi, ARBs, diuretics, beta-blockers).
STEP 2 — Rule In / Rule Out
Is serum potassium below the laboratory reference range? If yes, proceed to correct hypokalemia; if no, evaluate for other causes of false-negative PA screen (e.g., interfering medications, suboptimal sample handling).
STEP 3 — Classify or Stratify
After correcting potassium to within the laboratory reference range, repeat PA screening (aldosterone, renin, ARR). If the repeat screen is positive (ARN >20 by immunoassay or >70 by LC-MS/MS-adjusted criteria, with suppressed renin), classify as likely PA; if negative, consider alternative explanations.
STEP 4 — Decide
If repeat screen is positive, initiate PA-specific diagnostic workup (e.g., adrenal venous sampling consideration); if repeat screen remains negative, reassess clinical suspicion and consider repeat screening in future if hypokalemia recurs or hypertension worsens.
Clinical Guardrails / Mimics / Pitfalls
Do not rule out PA based on a single negative screen in hypokalemia; do not repeat PA screening without first correcting potassium to normal range; do not ignore interfering medications that may suppress aldosterone or alter renin; avoid using hemolyzed samples for potassium measurement.
Concrete Clinical Example
A 52-year-old hypertensive patient with serum K+ 2.8 mmol/L has an initial ARR of 15 (immunoassay) with suppressed renin. After KCl repletion to 4.2 mmol/L, repeat ARR is 38 with suppressed renin, prompting adrenal venous sampling.
Source: Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2025, DOI: 10.1210/clinem/dgaf284
TODO: consider adding scripts/calc.py for the endo-pa-repeat-screen-hypokalemia calculator